Taglutimide
Taglutimide (Biglumide; K 2004) is an orally active hypnotic agent. Taglutimide lowers plasma levels of diphenhydramine in rats and shortens the duration of anesthesia. Taglutimide is used in research on neurological disorders such as sedation and hypnosis[1][2].
Product Specifications
CAS Number
14166-26-8
Product Name Alternative
Biglumide; K 2004
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Neurological Disease
Smiles
O=C1NC(C(CC1)N2C(C3C(C4CCC3C4)C2=O)=O)=O
Molecular Formula
C14H16N2O4
Molecular Weight
276.29
References & Citations
[1]Jurecka W, et al. Teratologisch-neurotoxische Prüfung von Biglumid (K-2004) und Thalidomid [Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide]. Arch Toxicol. 1977 Jun 18;37 (2) :165-72. German. |[2]Wiener H, et al. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. Eur J Drug Metab Pharmacokinet. 1980;5 (2) :93-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127230-APC 100 µL
GCLC (Glutamate-cysteine Ligase Catalytic Subunit, GCL, GLCL, GLCLC, Gamma-glutamylcysteine Synthetase, Gamma-ECS, GCS Heavy Chain) (APC)
Sign In for Pricing
View Details ARP63617_P050-FITC 100 µL
SYNC Antibody - N-terminal region : FITC (ARP63617_P050-FITC)
Sign In for Pricing
View Details 
GTR15314035 1 Vial
Lentiviral human POLR2B shRNA (UAS) - Lentiviral human POLR2B shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details